FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16438311000001101: Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57587501000001115 Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57587601000001116 Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet Has VMP Ubidecarenone 30mg / Magnesium oxide 150mg tablets true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet Has specific active ingredient Magnesium oxide true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet Has specific active ingredient Ubidecarenone true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Coenzyme Q10 30mg + Magnesium 150mg tablets (Wassen International Ltd) 30 tablet Is a True Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start